{"id":"W4407296520","doi":"10.1158/2767-9764.crc-24-0407","title":"Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bayer","keywords":"Nivolumab; Medicine; Tolerability; Adverse effect; Oncology; Internal medicine; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009257257,0.0007926045,0.001335535,0.0002836591,0.0003558463,0.0006557141,0.0004854005,0.0007200083,0.001197206],"category_scores_gemma":[0.0006038346,0.000313985,0.0008355551,0.0002829503,0.0005847092,0.0004639533,0.0002076274,0.002030395,0.0004122452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001085372,"about_ca_system_score_gemma":0.001341422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006273241,"about_ca_topic_score_gemma":0.001530467,"domain_scores_codex":[0.9996221,0.0001590044,0.00002863042,0.00007897441,0.0000568256,0.00005444571],"domain_scores_gemma":[0.9995621,0.00005793307,0.0001132479,0.0000360199,0.00003389767,0.0001969124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.369013,0.1106721,0.04036192,0.001751517,0.003319272,0.0007594256,0.0006037532,0.006248739,0.1523919,0.0002692951,0.005230924,0.3093782],"study_design_scores_gemma":[0.3031383,0.61285,0.05279377,0.0000970421,0.001065877,0.001141419,0.0001001819,0.005628549,0.01712732,0.0002393389,0.005769633,0.00004859655],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965029,0.001862167,0.0002544341,0.0001867167,0.00002975528,0.0003661377,0.0001479126,0.00003181256,0.0006182111],"genre_scores_gemma":[0.9971124,0.0007737497,0.0006966554,0.0002953197,0.00006801556,0.0003230428,0.000366415,0.000009542003,0.0003547885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001335535,"threshold_uncertainty_score":0.007874966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04313230397912114,"score_gpt":0.439449919810687,"score_spread":0.3963176158315659,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}